SLC6A4 and Parkinson disease: Imaging studies with Position Emission Tomography (PET) inferred that the density of 5-HT transporters declines in the striatum of PD patients in a stage-dependent manner [12] whilst a global reduction of presynaptic serotonergic terminals occurs, however without a clear correlation with disease duration, motor disability and chronic exposure to dopamine replacement therapy [13].